Zr-DFO-girentuximab

DRUG2 trials

Sponsors

Stichting Radboud universitair medisch centrum, Ospedale San Raffaele S.r.l.

Conditions

Metastatic renal cell carcinomaVon-Hippel Lindau (VHL) Disease

Phase 2

CAT-VHL - Exploring the role of Carbonic Anhydrase IX as diagnostic and Theranostic target in Von-Hippel Lindau disease

Not yet recruitingCTIS2024-515679-36-01

Ospedale San Raffaele S.r.l.Von-Hippel Lindau (VHL) Disease

Target: 38Updated: 2026-01-08

Phase 3

Intrapatient comparison of 68Ga-gozetotide (PSMA) PET and 89Zr-girentuximab PET in clear cell renal cell carcinoma (ISEE-RCC)

RecruitingCTIS2024-514181-39-00

Stichting Radboud universitair medisch centrumMetastatic renal cell carcinoma

Start: 2025-09-23Target: 20Updated: 2025-02-25